Lobbying Activity Report

1326-36801

Organization: Eli Lilly Canada Inc.
Associated registration: 9573-1326-26
Lobbying Activity date: 2024-08-02
Arranged a meeting: No
Posted date: 2024-09-16

In-house lobbyists who participated in the lobbying activity: Jill Daley
Christopher Praught
Senior Public Office Holders who were lobbied in this activity: John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement, Health

Chris Ingram, Director
Health

Edmond Margawang, Director
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Health - Development, establishment, amendment or termination of any program, policy or decision, with respect to:
Policy discussions related to Patented Medicine Prices Review Board (PMPRB) and pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design and health system design
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Kenneth L Custer
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: